Hanseatic Management Services Inc Global Blood Therapeutics, Inc. Transaction History

Hanseatic Management Services Inc

  • $70.1 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 22, 2020
BUY
$41.72 - $87.2 $145,561 - $304,240
3,489 New
3,489 $178,000
Q2 2018

Aug 14, 2018
SELL
$38.7 - $50.15 $135,875 - $176,076
-3,511 Closed
0 $0
Q1 2018

May 02, 2018
BUY
$39.6 - $65.9 $139,035 - $231,374
3,511 New
3,511 $170,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email